Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea · Delayed Price · Currency is KRW 7,750.00
+550.00 (7.64%)
Apr 3, 2026, 3:30 PM KST
Oncocross Market Cap
Oncocross has a market cap or net worth of 94.52 billion as of April 2, 2026. Its market cap has decreased by -14.46% in one year.
Market Cap
94.52B
Enterprise Value
76.45B
Revenue
370.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
7,750.00
Market Cap Chart
Since December 18, 2024, Oncocross's market cap has decreased from 106.25B to 94.52B, a decrease of -11.04%. That is a compound annual growth rate of -8.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2026 | 94.52B | -17.97% |
| Dec 30, 2025 | 115.23B | 53.28% |
| Dec 30, 2024 | 75.18B | -29.24% |
| Dec 18, 2024 | 106.25B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 210.57B |
| MedPacto | 202.57B |
| Vaxcell-Bio Therapeutics | 188.15B |
| Macrogen | 177.04B |
| ENCell | 175.65B |
| iNtRON Biotechnology | 125.07B |
| Amicogen | 114.49B |
| CG Invites | 114.03B |